OPKO Diagnostics, LLC

OPKO Diagnostics, LLC is a subsidiary of OPKO Health, Inc., dedicated to developing innovative in-vitro medical diagnostic products. The company focuses on transitioning complex laboratory tests to point-of-care settings, such as physician offices and bedside environments. Their technology allows users to perform laboratory-quality assays quickly and efficiently, enhancing rapid diagnostics outside traditional labs. The company operates through BioReference Laboratories, one of the largest clinical reference laboratories in the U.S., serving around 11 million patients annually. BioReference offers a wide range of clinical diagnostic tests, including blood, urine, and tissue analysis, which support healthcare providers and patients in various specialty areas. OPKO Diagnostics also features proprietary diagnostic tests and equipment, including the Spectral SLO OCT system and ultrasound products, contributing to improved medical testing accessibility and clinical decision-making. Headquartered in Woburn, Massachusetts, OPKO Diagnostics employs between 201-500 people and generates estimated revenues between $25 million and $75 million. The company is committed to enhancing patient outcomes through advanced diagnostic tools and integrated healthcare solutions.

• Employees 25